Qure.ai builds deep-learning diagnostic tools for radiology workflows across TB, lung cancer, and stroke management. The tech stack reveals a hybrid approach: Python + LLM frameworks (LangChain, Haystack, Pydantic AI, OpenAI, Anthropic) alongside enterprise infrastructure (SAP, Oracle, Active Directory), indicating both AI model development and healthcare systems integration. Active projects span population surveillance, pandemic preparedness, and payer-facing value demonstrations—suggesting a shift from purely clinical tools toward health-system procurement and real-world evidence gathering.
Notable leadership hires: Director Sales
Qure.ai is a health tech company that develops AI-powered diagnostic solutions for clinical imaging, focused on tuberculosis, lung cancer, and stroke identification and management. The company serves clinicians, healthcare systems, pharmaceutical organizations, and medical device manufacturers across global markets. Founded in 2016, it operates with 51–200 employees across India, Mozambique, Kenya, Mexico, Canada, UAE, and Nigeria. The product mix spans three disease verticals and reflects a scaling healthcare IT business navigating both clinical validation and commercial health-system procurement.
The company standardizes on Python with LangChain, Haystack, and Pydantic AI for application logic, integrating OpenAI and Anthropic LLMs. Enterprise data flows through Oracle and SAP systems.
The company actively hires across India, Mozambique, Kenya, Mexico, Canada, United Arab Emirates, and Nigeria—reflecting a distributed global operations model.
Other companies in the same industry, closest in size